The transradial access devices market is projected to reach USD 2.18 Billion by 2022 from USD 1.52 Billion in 2017, at a CAGR of 7.5 percent. The increasing prevalence of obesity, growing preference for interventional procedures using radial artery access, technological advancements, rising prevalence of lifestyle diseases, and increasing number of chemotherapy procedures globally are factors expected to drive the market.
By product, transradial access devices market is segmented into catheters, guidewires, sheaths and sheath introducers, and accessories (needles and cannulas). Catheters market is expected to grow with highest growth rate owing to factors such as the increasing incidence of lifestyle-related diseases such as CVD, obesity, and diabetes and the growing number of interventional and angiography procedures.
On the basis of application, the transradial access devices market is segmented as drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. Drug administration market is estimated to grow with highest CAGR owing to factors such as high usage of radial access devices for drug administration for treatment of infections and cancer.
The transradial access devices market is segmented on the basis of end users into hospitals, clinics and ambulatory care centers, and other end users (nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). The hospitals segment is expected to grow with highest growth rate owing to the large number of transradial procedures performed in hospital settings.
By geography, transradial access devices market is segmented as North America, Europe, Asia Pacific and RoW. North America, market is likely to grow with highest growth rate owing to factors such as growing prevalence of CVDs, rising number of conferences and workshops, the large number of cancer patients, and increase in research and clinical trials for vascular access devices. – Markets and Markets